Publikationen 2017
Wallhausser-Franke E, D'Amelio R, Glauner A, Delb W, Servais JJ, Hormann K, Repik I.
Transition from Acute to Chronic Tinnitus: Predictors for the Development of Chronic Distressing Tinnitus.
Front Neurol. 2017;8:605. Impact Punkte: 3,6 Abstract
Klingele M, Stadler T, Fliser D, Speer T, Groesdonk HV, Raddatz A.
Long-term continuous renal replacement therapy and anticoagulation with citrate in critically ill patients with severe liver dysfunction.
Crit Care. 2017;21(1):294. Impact Punkte: 5,4 Abstract
Ebrahimi-Fakhari D, Poryo M, Graf N, Zemlin M, Flotats-Bastardas M, Heine G, Ragoschke-Schumm A, Meyer S.
Optimized care in Patients with Rare Diseases: TSC at the Center for Rare Diseases (ZSEUKS) at Saarland University Medical Center, Germany.
Klin Padiatr. 2017;229(6):311-315. Impact Punkte: 0,9 Abstract
Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.
HDL cholesterol: reappraisal of its clinical relevance.
Clin Res Cardiol. 2017;106(9):663-675. Impact Punkte: 4,8 Abstract
Heine GH, Rogacev KS, Weingartner O, Marsche G.
Still a reasonable goal: Targeting cholesterol in dialysis and advanced chronic kidney disease patients.
Semin Dial. 2017;30(5):390-394. Impact Punkte: 1,7 Abstract
Stroeder J, Klingele M, Bomberg H, Wagenpfeil S, Buecker A, Schaefers HJ, Katoh M, Minko P.
Occurrence and severity of non-occlusive mesenteric ischemia (NOMI) after cardiovascular surgery correlate with preoperatively assessed FGF-23 levels.
PLoS One. 2017;12(8):e0182670. Impact Punkte: 2,8 Abstract
Weingartner O, Lutjohann D, Cremers B, Seiler-Mussler S, Schott HF, Kerksiek A, Friedrichs S, Meyer S, Ulbricht U, Zawada A, Laufs U, Scheller B, Fliser D, Bohm M, Heine G.
Detailed analysis of cholesterol metabolism predicts cardiovascular events in patients admitted for coronary angiography.
Atherosclerosis. 2017;263:e189. Impact Punkte: 4,2 Abstract
Silbernagel G, Scharnagl H, Kleber ME, Grammer TB, Delgado G, Stojakovic T, Gary T, Ritsch A, Zewinger S, Speer T, Landmesser U, Marz W.
J-shaped association of circulating apolipoprotein C3 with cardiovascular mortality.
Atherosclerosis. 2017;263:e89-e90. Impact Punkte: 4,2 Abstract
Schwarz V, Heine GH, Bohm M, Scheller B.
Hydration and contrast-induced kidney injury.
Lancet. 2017;390(10093):452. Impact Punkte: 47,8 Abstract
Ludwig N, Becker M, Schumann T, Speer T, Fehlmann T, Keller A, Meese E.
Bias in recent miRBase annotations potentially associated with RNA quality issues.
Sci Rep. 2017;7(1):5162. Impact Punkte: 4,3 Abstract
Untersteller K, Seiler-Mussler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.
Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.
Nephrol Dial Transplant. 2017. Impact Punkte: 4,5 Abstract
Zewinger S, Kleber ME, Tragante V, McCubrey RO, Schmidt AF, Direk K, Laufs U, Werner C, Koenig W, Rothenbacher D, Mons U, Breitling LP, Brenner H, Jennings RT, Petrakis I, Triem S, Klug M, Filips A, Blankenberg S, Waldeyer C, Sinning C, Schnabel RB, Lackner KJ, Vlachopoulou E, Nygard O, Svingen GFT, Pedersen ER, Tell GS, Sinisalo J, Nieminen MS, Laaksonen R, Trompet S, Smit RAJ, Sattar N, Jukema JW, Groesdonk HV, Delgado G, Stojakovic T, Pilbrow AP, Cameron VA, Richards AM, Doughty RN, Gong Y, Cooper-DeHoff R, Johnson J, Scholz M, Beutner F, Thiery J, Smith JG, Vilmundarson RO, McPherson R, Stewart AFR, Cresci S, Lenzini PA, Spertus JA, Olivieri O, Girelli D, Martinelli NI, Leiherer A, Saely CH, Drexel H, Mundlein A, Braund PS, Nelson CP, Samani NJ, Kofink D, Hoefer IE, Pasterkamp G, Quyyumi AA, Ko YA, Hartiala JA, Allayee H, Tang WHW, Hazen SL, Eriksson N, Held C, Hagstrom E, Wallentin L, Akerblom A, Siegbahn A, Karp I, Labos C, Pilote L, Engert JC, Brophy JM, Thanassoulis G, Bogaty P, Szczeklik W, Kaczor M, Sanak M, Virani SS, Ballantyne CM, Lee VV, Boerwinkle E, Holmes MV, Horne BD, Hingorani A, Asselbergs FW, Patel RS, Kramer BK, Scharnagl H, Fliser D, Marz W, Speer T.
Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
Lancet Diabetes Endocrinol. 2017;5(7):534-543. Impact Punkte: 19,7 AbstractComment
Fischer M, Leyking S, Schafer M, Elsasser J, Janssen M, Mihm J, van Bentum K, Fliser D, Sester M, Sester U.
Donor-specific alloreactive T cells can be quantified from whole blood, and may predict cellular rejection after renal transplantation.
Eur J Immunol. 2017;47(7):1220-1231. Impact Punkte: 4,2 Abstract
Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.
Reprint of: MicroRNA profiling of human intermediate monocytes.
Immunobiology. 2017;222(6):831-840. Impact Punkte: 2,7 Abstract
Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G.
The systemic nature of CKD.
Nat Rev Nephrol. 2017;13(6):344-358. Impact Punkte: 12,1 Abstract
Schlitt A, Sester U, Sester M, Seiler-Mussler S, Brandenburg V, Schaffner E, Heine GH.
Letter to the Editor regarding Dounousi E et al. Intact FGF23 and alpha-Klotho during acute inflammation/sepsis in CKD patients. Eur J Clin Invest. 2016;46:234-41.
Eur J Clin Invest. 2017;47(6):468-469. Impact Punkte: 2,7 Abstract
Kranz J, Schmidt S, Lebert C, Schneidewind L, Vahlensieck W, Sester U, Funfstuck R, Helbig S, Hofmann W, Hummers E, Kunze M, Kniehl E, Naber K, Mandraka F, Mundner-Hensen B, Schmiemann G, Wagenlehner FME.
[Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients : Update 2017 of the interdisciplinary AWMF S3 guideline].
Urologe A. 2017;56(6):746-758. Impact Punkte: 0,3 Abstract
Zewinger S, Kleber ME, Rohrer L, Lehmann M, Triem S, Jennings RT, Petrakis I, Dressel A, Lepper PM, Scharnagl H, Ritsch A, Thorand B, Heier M, Meisinger C, de Las Heras Gala T, Koenig W, Wagenpfeil S, Schwedhelm E, Boger RH, Laufs U, von Eckardstein A, Landmesser U, Luscher TF, Fliser D, Marz W, Meinitzer A, Speer T.
Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease.
Eur Heart J. 2017;38(20):1597-1607. Impact Punkte: 20,2 Abstract
Schoch J, Rohrer TR, Kaestner M, Abdul-Khaliq H, Gortner L, Sester U, Sester M, Schmidt T.
Quantitative, phenotypical and functional characterization of cellular immunity in pediatric individuals with Down syndrome.
J Infect Dis. 2017;215(10):1619-1628. Impact Punkte: 6,3 Abstract
Schlieper G, Schwenger V, Remppis A, Keller T, Dechend R, Massberg S, Baldus S, Weinreich T, Hetzel G, Floege J, Mahfoud F, Fliser D.
[Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].
Internist (Berl). 2017;58(5):512-521. Impact Punkte: 0,4 Abstract
Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, Halimi JM, Heine GH, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verhaar MC, Wiecek A, Wuerzner G, London GM, Zoccali C.
Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).
Nephrol Dial Transplant. 2017;32(4):620-640. Impact Punkte: 4,5 Abstract
Akhmedov A, Camici GG, Reiner MF, Bonetti N, Costantino S, Holy EW, Spescha RD, Stivala S, Schaub Clerigue A, Speer T, Breitenstein A, Manz J, Lohmann C, Paneni F, Beer JH, Luscher TF.
Endothelial LOX-1 Activation Differentially Regulates Arterial Thrombus Formation Depending on oxLDL Levels: Role of the Oct-1/SIRT1 and ERK1/2 Pathways.
Cardiovasc Res. 2017;113(5):498-507. Impact Punkte: 5,9 Abstract
Heine GH, Brandenburg V.
Anticoagulation, atrial fibrillation, and chronic kidney disease-whose side are you on?
Kidney Int. 2017;91(4):778-780. Impact Punkte: 8,4 Abstract
Bomberg H, Klingele M, Wagenpfeil S, Spanuth E, Volk T, Sessler DI, Schafers HJ, Groesdonk HV.
Presepsin (sCD14-ST) Is a Novel Marker for Risk Stratification in Cardiac Surgery Patients.
Anesthesiology. 2017;126(4):631-642. Impact Punkte: 5,8 Abstract
Zawada AM, Zhang L, Emrich IE, Rogacev KS, Krezdorn N, Rotter B, Fliser D, Devaux Y, Ziegler-Heitbrock L, Heine GH.
MicroRNA profiling of human intermediate monocytes.
Immunobiology. 2017;222(3):587-596. Impact Punkte: 2,7 Abstract
Fliser D, Dellanna F, Koch M, Wiggenhauser A.
Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
Nephrol Dial Transplant. 2017;32(2):279-287. Impact Punkte: 4,5 Abstract
Marz W, Kleber ME, Scharnagl H, Speer T, Zewinger S, Ritsch A, Parhofer KG, von Eckardstein A, Landmesser U, Laufs U.
[Clinical importance of HDL cholesterol].
Herz. 2017;42(1):58-66. Impact Punkte: 0,8 Abstract
Bauer L, Kern S, Rogacev KS, Emrich IE, Zawada A, Fliser D, Heinemann A, Heine GH, Marsche G.
HDL Cholesterol Efflux Capacity and Cardiovascular Events in Patients With Chronic Kidney Disease.
J Am Coll Cardiol. 2017;69(2):246-247. Impact Punkte: 19,9 Abstract
Simic B, Mocharla P, Crucet M, Osto E, Kratzer A, Stivala S, Kuhnast S, Speer T, Doycheva P, Princen HM, van der Hoorn JW, Jukema JW, Giral H, Tailleux A, Landmesser U, Staels B, Luscher TF.
Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.
Atherosclerosis. 2017;257:186-194. Impact Punkte: 4,2 Abstract